Bicocca Open Archive

Logo unimib boa
PIAZZA, ROCCO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.738
EU - Europa 12.626
AS - Asia 12.081
SA - Sud America 1.839
AF - Africa 224
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 16
Totale 48.548
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.195
SG - Singapore 4.727
IT - Italia 3.231
CN - Cina 2.870
DE - Germania 2.587
RU - Federazione Russa 1.736
HK - Hong Kong 1.558
BR - Brasile 1.490
VN - Vietnam 1.424
SE - Svezia 1.233
IE - Irlanda 1.193
GB - Regno Unito 589
UA - Ucraina 571
CA - Canada 391
FI - Finlandia 325
FR - Francia 305
IN - India 275
ID - Indonesia 240
KR - Corea 202
TR - Turchia 189
AR - Argentina 153
PL - Polonia 131
BD - Bangladesh 129
NL - Olanda 125
AT - Austria 124
JP - Giappone 120
ZA - Sudafrica 109
DK - Danimarca 104
MX - Messico 94
ES - Italia 83
BE - Belgio 77
IQ - Iraq 63
EC - Ecuador 59
CH - Svizzera 44
LT - Lituania 44
PK - Pakistan 37
CO - Colombia 34
SA - Arabia Saudita 34
VE - Venezuela 33
MA - Marocco 30
BG - Bulgaria 28
UZ - Uzbekistan 26
CZ - Repubblica Ceca 25
IR - Iran 25
EU - Europa 22
EG - Egitto 20
PE - Perù 20
AE - Emirati Arabi Uniti 19
CL - Cile 19
KE - Kenya 19
AZ - Azerbaigian 18
PY - Paraguay 18
JO - Giordania 17
IL - Israele 15
TN - Tunisia 13
DO - Repubblica Dominicana 12
NP - Nepal 12
NO - Norvegia 11
AU - Australia 9
ET - Etiopia 9
GR - Grecia 9
MY - Malesia 9
RO - Romania 9
AL - Albania 8
BO - Bolivia 8
KG - Kirghizistan 8
KZ - Kazakistan 8
PH - Filippine 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
HN - Honduras 7
JM - Giamaica 7
CR - Costa Rica 6
AM - Armenia 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
DZ - Algeria 4
GT - Guatemala 4
OM - Oman 4
PT - Portogallo 4
SC - Seychelles 4
BM - Bermuda 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
GE - Georgia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LY - Libia 3
MK - Macedonia 3
MU - Mauritius 3
RS - Serbia 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
Totale 48.514
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.898
Singapore 2.806
Ashburn 2.080
Frankfurt am Main 1.582
Hong Kong 1.543
Woodbridge 1.224
Milan 1.193
Dublin 1.162
Chandler 1.067
Fairfield 965
Houston 775
Wilmington 747
Dallas 737
New York 596
Jacksonville 530
Dearborn 507
Beijing 487
Hefei 464
Los Angeles 457
Santa Clara 427
Ho Chi Minh City 423
Seattle 418
Hanoi 338
Cambridge 307
Princeton 302
Shanghai 239
Jakarta 211
Göttingen 205
Seoul 190
Munich 175
São Paulo 175
Buffalo 173
Moscow 168
Nanjing 166
Chicago 157
The Dalles 157
Altamura 142
Helsinki 122
Lawrence 120
Toronto 111
Boardman 99
Nuremberg 97
Tokyo 94
Guangzhou 91
Warsaw 90
Lachine 85
Kent 83
Rome 83
London 82
San Diego 81
Brussels 72
Turku 72
Fürstenwalde 71
Stockholm 71
Denver 68
Orem 67
Montreal 64
Monza 64
Romola 63
Vienna 63
Council Bluffs 62
Johannesburg 62
Atlanta 60
Chennai 59
Fremont 58
Dong Ket 57
Nanchang 55
Andover 54
Ottawa 53
Poplar 53
Shenyang 52
Tianjin 52
Boston 51
Brooklyn 51
Lissone 49
Kocaeli 46
Rio de Janeiro 46
Haiphong 45
Turin 45
Desio 44
San Jose 44
Ankara 42
Da Nang 42
Phoenix 42
Hebei 41
Changsha 39
Assago 38
Mexico City 37
Düsseldorf 35
Salt Lake City 35
Jinan 34
Sesto San Giovanni 34
Jiaxing 33
Lappeenranta 33
Carate Brianza 31
Hangzhou 30
Pune 30
San Francisco 30
Como 29
Falls Church 29
Totale 31.868
Salva come PNG Salva come JPEG
Nome #
Longitudinal cancer evolution from single cells 561
Personalized therapy design for liquid tumors via optimal control theory 513
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 513
Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations 507
VERSO: a comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples 461
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 451
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 442
An Optimal Control Framework for the Automated Design of Personalized Cancer Treatments 431
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene 410
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 404
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 400
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 395
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 383
VERSO: a comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples 382
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 381
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 379
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 364
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 364
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 362
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization 362
LACE: Inference of cancer evolution models from longitudinal single-cell sequencing data 360
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 359
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 358
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 356
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 354
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 353
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 352
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 349
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 347
Variant calling from scRNA-seq data allows the assessment of cellular identity in patient-derived cell lines 344
Imatinib long term effects study: three years of follow-up and assessment 337
Hif1a: A putative modifier of hemochromatosis 325
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 322
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 322
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 319
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib 314
VirMutSig: Discovery and assignment of viral mutational signatures from sequencing data 314
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 311
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 310
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 310
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 307
Chronic myeloid leukemia: Second-line drugs of choice 306
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 305
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 304
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 302
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 300
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 298
Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data 298
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL) 293
Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by leguay et al 287
Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer 285
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 282
A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation 282
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma 280
Idiopathic erythrocytosis: a germline disease? 279
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling 279
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 278
A New BCR-ABL1 Mutation (L248R) Is Highly Resistant to Imatinib, Bosutinib, Nilotinib and Dasatinib, but Can Be Inhibited by AP-24534 and DCC-2036 277
Choosing the right TKI for chronic myeloid leukemia: when the truth lies in "long-term" safety and efficacy 276
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 276
LACE 2.0: an interactive R tool for the inference and visualization of longitudinal cancer evolution 275
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex 274
Whole-Exome Sequencing Data - Identifying Somatic Mutations 274
Human chromosome 18 and acrocentrics: A dangerous liaison 274
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 273
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 271
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 271
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 269
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 269
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 268
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 267
Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity 265
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 263
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 261
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 259
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 256
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 255
Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias 254
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation 254
In Vitro and in Vivo Characterization of Bosutinib as Substrate of the Pglycoprotein Efflux Transporter 252
Reply to P. Laneuville et al 252
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 249
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 249
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 249
Phase ii study with crizotinib in patients with anaplastic lymphoma kinase (alk)-positive lymphoma relapsed/refractory to chemotherapy 239
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 238
Highly sensitive mutations detection in BCR-ABL positive leukemia prior and during imatinib treatment 238
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 238
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 237
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 235
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 234
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses 232
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 231
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 229
Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition 226
Germ-Line TP53 Mutation in an Adolescent With CMML/Atypical CML and Familiar Cancer Predisposition 225
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 224
Early detection and improved genomic surveillance of SARS-CoV-2 variants from deep sequencing data 222
Antibody Deficiency in Patients with Biallelic KARS1 Mutations 222
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 222
Totale 30.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.655 0 0 0 0 0 0 513 448 453 463 342 436
2021/20223.341 313 301 354 244 233 295 225 183 183 227 295 488
2022/20235.119 604 1.360 515 520 400 631 90 242 313 100 183 161
2023/20244.287 162 187 223 260 506 1.076 753 151 308 145 97 419
2024/20259.968 486 867 610 551 843 425 673 370 875 1.608 931 1.729
2025/202613.388 2.912 1.643 1.966 2.898 2.700 1.174 95 0 0 0 0 0
Totale 49.797